



Abstract           
ANTIDIABETIC EFFECTS OF MEDICINAL PLANTS. 
 
Diabetes is a chronic disorder that is characterized by an increase 
in blood glucose (hyperglycemia) with alteration of protein, 
carbohydrates, and fat metabolism. Consequently, it can lead to renal 
failure, atherosclerosis, nerve damage, blindness, and coronary heart 
disease. It is also known as the 5
th
 leading cause of death. Although, 
there are numerous types of glucose-lowering drugs that exhibit anti-
diabetic effects but results of treatment in patients are still not so 
perfect. Therefore, many treatments that include the use of medicinal 
plants are suggested and encouraged. Medical plants are believed to 
contain chemical substances with potential curative effects and can 
often have anti-diabetic effects. This study introduced about 23 
effective medicinal plants reported by various experimental 
researchers with the curative potential to treat diabetes. Although, 
most of the research used animal models, there is a clear indication 
that medicinal plants with anti-diabetic potentials are being 
investigated by several researchers. However, there is a need for 
further research to be conducted with isolated bioactive ingredients 
present in these plants in order to have potential ingredients that 
could be used as a pharmacological agent in the treatment of diabetes 
mellitus with fewer adverse effects. Again, the mechanisms of action 
of these medicinal plants in ameliorating diabetes need to be 
investigated. 
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plants, hyperglycemia, hypoglycemia, insulin, antioxidants.– 
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Introduction 
Diabetes is a chronic disorder characterized by 
an increase in blood glucose (hyperglycemia) with 
alteration of protein, carbohydrates and fat 
metabolism [1, 2]. It is caused by either insulin 
deficiency or malfunction [2]. Diabetes mellitus 
leads to high blood glucose level, which causes 
acute complications such as hyperglycemia and 
hypoglycemia accompanied with long-term 
complications in many organs of the body, which 
may result to increased tendency of renal failure, 
atherosclerosis, nerve damage, blindness and 
coronary heart disease resulting in increasing 
disability [3]. 
However, it can be classified as either Type I 
diabetes, Type II diabetes or gestational diabetes 
mellitus on the basis of clinical representation of 
the disorder [4]. According to statistics, in 2012, 
diabetes mellitus affects about 200 million people 
in the world [5], and it is estimated to rise to over 
366 million in the year 2030 [6]. It is also known as 
the 5
th
 leading cause of death [7]. Oxidative stress 
(OS) plays a major role in the pathogenesis of 
micro-vascular and macro-vascular diabetic 
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complications. Hyperglycemia, insulin resistance 
(IR), and dyslipidemia are present in diabetic 
patients due to increased OS [8]. Recently, there are 
different treatments available to control diabetes 
which includes insulin therapy, diet and 
pharmacotherapy. Additionally, there are numerous 
types of glucose-lowering drugs that exhibit anti-
diabetic effects via diverse mechanisms of action 
[9]. But, inspect of the progress significantly made 
in the treatment of diabetes, the results of treatment 
in patients is still not so perfect. These treatments 
are known to have disadvantages which include 
side effects, drug resistance (reduction of 
efficiency), and even toxicity [9]. For instance, 
glucose-lowering drugs are not able to control 
presence of excess lipids in the blood 
(hyperlipidemia) [10]. 
Recently, many treatments that include the use 
of medicinal plants are suggested and encouraged 
[11, 12, 13]. Medical plants are believed to contain 
chemical substances such as flavonoids, 
carotenoids, terpenoids, glycosides, alkaloids with 
potential curative effects and can often have anti-
diabetic effects [14, 15]. The anti-hyperglycemic 
effects that occur from treatment with plants are 
most times due to the ability of the plants to 
improve the action of pancreatic tissue, which is 
carried out by either increased insulin secretions or 
reduced intestinal absorption of glucose [9]. The 
increasing number of people with diabetes has 
raised a concern for the medical community and the 
public at large. The aim of this study is to introduce 
a number of effective medicinal plants with 
curative potential to treat diabetes and to present 
other mechanisms of plant compounds used to 
reduce blood glucose levels. This study will help 
the medical community and the world at large to 
find and use a suitable pharmacological agent to 
treat diabetes with less adverse effects. 
Acacia nilotica 
Acacia nilotica belong to the family 
Mimosaceae. In a study that was carried out to 
evaluate the efficiency of Acacia nilotica leaf to 
ameliorate diabetic complications, oral 
administration of 50 mg/kg and 200 mg/kg of 
Acacia nilotica leaf extract to alloxanized mice for 
20 days significantly lowered systemic glucose load 
and insulin resistance without showing any 
significant effects on insulin sensitivity. 
Additionally, lowered level of HbA1c and 
improved glucose utilization supported the anti-
hyperglycemic properties of Acacia nilotica leaf. 
Renal (creatinine, blood urea nitrogen (BUN)) and 
hepatic (AST, ALT) and injury markers were 
lowered and there was normalization of 
dyslipidemia. Furthermore, peroxidase and catalase 
(CAT) activities in liver, skeletal muscle and 
kidney increased. It was reported that the plant 
contains phenolic, flavonoid, catechol, tocopherol 
and β-sitosterol [16]. In another experiment to 
determine the effect of Acacia nilotica leaves 
extract in reducing the high level of glucose and 
lipid in the blood in alloxanized diabetic rats. Oral 
administration of Acacia nilotica aqueous methanol 
leaves extract for 1–3 weeks significantly decreased 
fasting blood glucose (FBG), low density 
lipoprotein (LDL), phospholipids, triglyceride 
(TG), total cholesterol (TC), and very low density 
lipoprotein (VLDL). In addition, the level of high 
density lipoprotein (HDL) and the level of serum 
insulin increased. The duration of these effects was 
noted after 2 weeks of treatment [8]. Also, 
200 mg/kg of Acacia nilotica fruit extract orally 
administered for 5 weeks to alloxan-induced 
diabetic rats significantly decreased serum level of 
LDL and TG, although, there was no significant 
change in the serum glucose concentrations of 
diabetic rats [17]. Another study used the Acacia 
nilotica pods extract to determine its therapeutic 
effect on streptozotocin (STZ) induced diabetic 
nephropathy in rat. In this experiment, 150 and 
300 mg/kg administration of the extract for 60 days 
decreased the blood glucose level, and restored 
creatinine, and serum urea. The normal 
histopathological architecture of kidney was 
restored, glomerular size and damaged area were 
ameliorated, and the adverse effect of diabetes on 
lipid peroxidation (LPO), superoxide dismutase 
(SOD) and glutathione (GSH) activity was 
attenuated [18]. Oral administration of Acacia 
nilotica leaves extract (300 mg/kg b.w), in 
comparison to glyburide (900 microgm/kg b.w) for 
3 weeks significantly decreased fasting blood 
glucose FBG and increased insulin level in STZ-
induced diabetic rats [19]. Also, administration of 
Acacia nilotica leaves extract resulted into 
hypoglycemic and anti-platelet aggregation in STZ 
induced diabetic rats [20]. In summary, aqueous 
methanol extract from Acacia nilotica (AN) fruits, 
bark, pods and seeds have been reported to be used 
traditionally for the treatment of diabetes [19, 33]. 
Adonsonia digitata 
Adonsonia digitata of the family Malvaceae 
have been reported to be traditionally used for the 
treatment of diabetes mellitus in Nigeria. The oral 
administration of the seed prepared by infusion was 
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reported to be used. Also the infusion of the 
powered fruit of Adonsonia digitata and cow milk 
was also reported in the study [21]. Traditionally, 
various parts of the Adonsonia digitata tree have 
been used to cure many clinical illnesses such as 
dysentery and diarrhea. Phytochemical screening 
has indicated that the leaf extract of Adonsonia 
digitata contains saponins, flavonoids, mucilage, 
alkaloids and steroids [22]. In an experimental 
research to determine and evaluate the 
hypolipidaemic and hyperglycaemic effects of 
methanolic extract of Adonsonia digitata leaves, 
oral administration of 200 mg/kg and 400 mg/kg of 
the extract for 6 weeks to STZ induced diabetic rats 
significantly decreased the blood glucose, TG, 
cholesterol, glycosylated hemoglobin, LDL, tumor 
necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), 
and malondialdehyde (MDA) levels by 46.7%, 
43%, 48.91%, 46.15%, 60%, 45.45%, 66% and 
30.4%, respectively, in comparison to the diabetic 
control group. Also, the decline of red blood cell 
(RBC) count, packed cell volume (PCV), 
hemoglobin level, HDL and erythropoietin 
concentration was mitigated. While the level of 
antioxidant enzymes, SOD and CAT were 
maintained with reduction in GSH and reduction of 
elevated white blood corpuscles (WBC) count [22]. 
Allium cepa 
Allium cepa (onions) belonging to the family 
Amaryllidaceae have been reported to have anti-
diabetic effects in different experimental 
researches. A study carried out to evaluate the 
effects of onion (Allium cepa) dried by heat 
treatment on FBG level and plasma lipid profile in 
STZ induced diabetic rats showed a significant 
lower level of FBG, TG, LDL and TC after 5% 
onion powered dried at -70°c in a lyophilizator was 
administered to the diabetic rats. In this experiment 
HDL level increased [23]. The fasting serum HDL 
was increased in an experiment carried out to 
determine the antioxidant activity and 
hypoglycemic effects of Allium cepa in STZ 
induced diabetic rats. In this experiment, 
lipoperoxide concentration and lipid hydroperoxide 
were not increased after administration of Allium 
cepa [24]. However, in a clinical study with type 1 
and type 2 diabetic patients, oral ingestion of crude 
Allium cepa (100g) by the diabetic patients caused a 
significant decrease in FBG level in type 1 diabetic 
patient by about 89 mg/dl in comparison to insulin 
(145 mg/dl), while in the type 2 diabetic patients, 
significant decrease in FBG level by 40 mg/dl was 
observed in relation to glibenclamide (81 mg/dl). In 
this same study, after 4 hours, induced 
hyperglycemia was significantly reduced by about 
120 mg/dl in patients with type 1 diabetes, in 
comparison to water (77 mg/dl) and insulin 
(153 mg/dl) with same dose of crude Allium cepa, 
while in type 2 diabetic patient, a significant 
reduction of about 159 mg/dl compared to water 
(55 mg/dl) and glibenclamide (114 mg/dl) was 
observed [25]. Onions is believed to contain 
flavonoids like quercetin and quercetrin. It also 
contains sulphur compounds like allyl propyl 
disulphide and cysteine [25]. These compounds are 
believed to have antibiotic, anticancer, 
hypocholesterolaemic, antithrombotic, antioxidant, 
antibacterial, antidiabetic and fibrinolytic effects 
[26, 27, 28, 29, 34, 35, 36, 37]. A bioactive 
flavonoid (Kaempferol-3-O-β-D-6{P- Coumaroyl} 
Glucopyranoside) that was isolated from Allium 
cepa was used to determine its antidiabetic effect 
on alloxan-induced diabetic male rate. The isolated 
compound administered at 25 mg/kg to the diabetic 
rats significantly decreased blood glucose in 
diabetic rats in a manner comparable to the effects 
obtained with 2 mg/kg of glibenclamide [30]. Also, 
supplementation of onion powder (7% w/w) 
administered to STZ-induced diabetic rat for 5 
weeks caused reduced level of blood glucose, 
triglyceride, total serum lipid, renal oxidative stress, 
and atherogenic index in comparison to the control 
groups. In this experiment, high density lipoprotein 
cholesterol/total cholesterol ratio increased [31]. 
Aqueous extract of onion exhibited an 
antithrombotic effect in STZ-induced diabetic rats 
[32]. 
Anacardium occidentalis  
Anacardium occidentalis (cashew) belongs to 
the family Anacardiaceae. The root, bark, stem and 
leaves of Anacardium occidentalis have been 
experimentally researched for their antidiabetic 
effects. For instance, in an experimental study, 
2 mg/100g-body weight of crude ethanolic extract 
of cashew root orally administered to adult guinea 
pigs and albino rats 3 times daily for 7 days 
significantly decreased plasma glucose level, 
cholesterol, liver glycogen and total lipid in guinea 
pig and albino rats after increased postprandial 
glucose level, although, plasma protein was not 
affected [38]. In essence, it could be concluded that 
ethanolic extract of cashew root can be used as a 
treatment and for the management of diabetes 
mellitus. Furthermore, isolated and characterized 
compounds (stigmast-4-en-3-ol and stigmast-4-en-
3-one) gotten from the hexane extract of the bark of 
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Anacardium occidentalis were used in an 
experiment to determine their hypoglycemic 
effects. In this experiment, intravenous 
administration of these compounds at 1.3 mg/kg 
b.w significantly reduced blood glucose level in 
normal, healthy dogs. It was hypothesized that 
these compounds presence in cashew bark could be 
responsible for its hypoglycemic effects [39]. Also, 
100 mg/kg of Anacardium occidentalis 
administered to alloxan-induced diabetic rats 
showed a significant increase in SOD activity [40]. 
In another experiment, when graded doses (100-
800 mg/kg p.o.) of aqueous and methanolic stem-
bark extracts of A. occidentale was administered to 
STZ induced diabetic rat, there was dose-
dependent, significant decrease in the blood glucose 
level of fasted normal and fasted diabetic rats. In 
the same study, a single dose of 800 mg/kg p.o., of 
Anacardium occidentalis stem-bark aqueous and 
methanolic extracts significantly decreased mean 
basal blood glucose level of fasted normal and 
fasted diabetic rats, although, it was reported that 
these extract is less potent in comparison to insulin. 
The authors concluded that the presence of 
terpenoid and/or coumarin in the extract could have 
caused the hypoglycemic effects but the mechanism 
is not yet fully understood [41]. In another study, 
administration of methanolic leaves extract of 
Anacardium occidentalis to alloxan-induced 
diabetic rat caused 79.2% change compared to 
Tolbutamide (63.1%) over 4 hours for moderately 
diabetic rat. In the experiment, when diabetes 
became severe, the extract reduced blood glucose 
level by 20.8% compared to Tolbutamide (47.63%) 
over 4 hours, although, the values were not 
considered to be significant. So, Anacardium 
occidentalis is believed to have similar ability in 
lowering blood glucose concentration compared to 
Tolbutamide (a reference drug) [42]. Injection of 
100 mg/kg of Anacardium occidentalis plant extract 
to neonatal STZ diabetic rats for 30 days caused a 
significant decrease in FBG level. The effects 
gotten are similar to the treatment with Pioglitazone 
(a standard drug). It was reported that, for future 
purpose, specific compound(s) responsible for the 
antidiabetic effects of Anacardium occidentalis is 
needed to be investigated [49]. 
Azadirachta indica 
Neem (A. indica) belongs to the family 
Meliaceae. Traditionally, maceration of 
Azadirachta indica leaves and Vernonia 
amygdalina (bitter leaf) has been reported to be 
orally used to treat diabetes in Nigeria [21]. 
Azadirachta indica is known to have hypoglycemic, 
hypolipidemic, hepatoprotective and 
immunostimulant properties [43, 44]. Some 
chemical compounds such as nimolinone, 
nimbocinone, kulactone, isonimocinolide, 
nimocinolides, nimbin, azadirachtin, salanin, 
flavonoids, meldenindiol, myricetin, 
isomargosinolide, margosinolide, desacetyldihydro-
nimbic acid and vilasinin have been isolated from 
A. indica leaves [45, 46, 47]. In an experimentally 
study, ethanolic extract of Vernonia amygdalina 
(VA) and Azadirachta indicia (AI) co-administered 
at 200 mg/kg, 50:50 to STZ-induced diabetic rats 
for 28 days reduced blood glucose, T3 and T4. 
Decreased glutathione peroxidase (GPx) and CAT 
activities were ameliorated and SOD activities 
increased. It was reported that the antidiabetic 
synergistic action of VA/AI could be due to insulin 
mimetic action, oxidative stress attenuation and β-
cell regeneration [48]. In another study, 
intraperitoneal injection of chloroform plant extract 
of Azadirachta indicia to STZ induced diabetic 
mice for 21 days regenerated insulin-producing 
cells with increase in plasma insulin and c-peptide 
levels. In the experiment, intestinal glucosidase 
activity reduced, glucose-6-phosphate 
dehydrogenase activity and hepatic, skeletal muscle 
glycogen content increased, and oral glucose was 
well tolerated [50]. A. indicia is reported to have 
bioactive compounds such as rutin, quercetin and 
nimbidin, which is said to be responsible for its 
hypoglycemic effects [51]. The hypoglycemic 
effect of combination of Azadirachta indicia and 
Gynura procumbens was carried out by Sunarwidhi 
et al. In the experiment, the macerated extracts 
administered to alloxan-induced diabetic rats for 15 
days significantly improved the morphology of β-
cells and the islets of Langerhans. Also, insulin 
expression increased and elevated-glucose 
concentration decreased [51]. Furthermore, in a 
randomized, double-blind, placebo-controlled 
clinical study, subjects with type 2 diabetes already 
placed on standard metformin therapy received 
different doses of neem for 12 weeks. In this 
experiment, neem at 125, 250, and 500mg doses 
significantly decreased postprandial blood sugar 
level, FBG, HbA1C and IR compared to the 
placebo group. Endothelial function improved OS 
and systemic inflammation decreased but there was 
no effects on lipid profile or platelet aggregation. It 
was suggested by the authors that neem may cure 
hyperglycemia, systemic inflammation and 
endothelial dysfunction in patients with type 2 
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diabetes in comparison to the effects of metformin 
[52]. In another study, butanol fraction of 
Azadirachta indica ethanol stem bark extract 
showed DDPH scavenging activity, FRAP activity, 
ameliorated oxidative injury in hepatic tissue by 
reducing malondialdehyde (MDA) concentration 
significantly, improved the activities of SOD and 
CAT, improved glucose uptake in psoas muscle 
with or without insulin, and inhibited activities of 
α-glucosidase and α-amylase. Sistosterol, 
campestrol, stigmasterol, squalene and nimbiol are 
reported to be present in Azadirachta indica. It was 
suggested that butanol and ethyl acetate fractions of 
A. indica may possibly have bioactive compounds 
with potentials to cure diabetes [53]. Impaired 
nerve functions and delayed nerve recovery 
occurring due to hyperglycemia-induced OS was 
ameliorated in STZ-induced diabetic rats by the 
action of A. indica flower extract at a dose of 250, 
500 or 750 mg/kg. In this experiment, functional 
recovery (motor and sensory functions) improved 
significantly, MDA levels significantly decreased, 
while SOD activity and axon density significantly 
increased. It was suggested by the authors that A. 
indica flower extract may have antioxidative effect 
[54]. In another study, combination of (1:1) 
aqueous extract of dried powder of Azadirachta 
indica (leaves) and Abroma augusta (root) orally 
administered to alloxan-induced diabetic rats once a 
day for 8 weeks significantly decrease blood sugar, 
serum lipids, formation of lipid peroxides and LPO 
with increased antioxidants (SOD, CAT, 
glutathione transferase and glutathione peroxidase). 
Decrease in body weight was also prevented by the 
extract [55]. Also, chloroform leaf extract of 
Azadirachta indica increased GSH, SOD, CAT and 
oxidized glutathione (GSSG), hepatic glycogen 
content, insulin plasma and glucose-6-phosphatase 
in STZ-induced diabetic rats after chronic oral 
administration of the extract for 28 days. 
Meanwhile, IR, lipid peroxidation and glucokinase 
(GK) decreased. It was reported that A. indica can 
be considered to be a potential antidiabetic-safe 
agent [56]. Absence of marked hyperglycemia, 
absence of diabetic nephropathy, absence of 
nodular glomerulosclerosis and absence of 
vacuolation of proximal tubule cells was observed 
in an experiment carried out to determine the 
ameliorative effects of ethanolic leaf extract of 
Azadirachta indica (500 mg/kg b.w) for 50 days on 
renal histological alterations in STZ-induced 
diabetic rats. It was stated that leaf extract of 
Azadirachta indica ameliorates hyperglycemia and 
diabetic nephropathy in rats [57]. 
Balanites aegyptiaca 
Balanites aegyptiaca commonly known as 
desert date tree belongs to the family Balanitiaceae. 
The kernel fruit was reported to contain 
polyphenols [58] and saponins [59]. Other bioactive 
compounds like flavonoids, alkaloids, tannins and 
vitamins have been reported in the fruit as well as 
the branches, leaves and roots of Balanites 
aegyptiaca [60, 61, 62]. In a study, 50 mg/kg b.w of 
crude extract, butanol or dichloromethane fraction 
of Balanites aegyptiaca administered to diabetic 
rats produced a decrease in plasma glucose, lactic 
acid, HbA1c, lipid profile, MDA, GSH levels, CAT 
and SOD activities with an increase in insulin and 
insulin receptor substrate 1 in rat pancreas. In 
essence, it was suggested by the authors that the 
hypoglycemic effect of Balanites aegyptiaca is due 
to the inhibition of the SAPK-JNK pathway [63]. In 
another study, B. aegyptia significantly decreased 
mean plasma glucose and MDA levels and 
significantly increased mean plasma insulin, total 
antioxidant capacity (TAC) levels, and liver-
pyruvate kinase (L-PK) in STZ-induced diabetic 
rats after oral administration of Balanites aegyptiaca 
fruits aqueous extract (1.5 g/kg b.w) daily for 45 
days. Size of the islets of Langerhans and weight of 
the pancreas increased and histoarchitecture also 
improved [64]. In a randomized double-blinded pilot 
clinical study to determine the antidiabetic efficacy 
of 70% ethanol extract of the pericarps of B. 
aegyptiaca on type 2 diabetic patients, B. aegyptiaca 
incorporation in hard gelatine capsules and 
administration at 400 mg/day for 8 weeks decreased 
postprandial plasma glucose, FBG, TG, LDL, TC, 
AST, ALT significantly. In the experiment, HDL 
increased. Administration of B. aegyptiaca capsules 
to type 2 diabetic patients caused significant 
improvements in glycaemic markers and lipid 
profile, without adverse effects or hypoglycemia 
[65]. Ethyl acetate extract from Balanites aegyptiaca 
administered at 10, 20 or 50 mg/kg b.w to 
experimental diabetic rats for 8 weeks lowered blood 
glucose level, HbA1c, MDA and vascular 
endothelial growth factor (VEGF) in diabetic retina. 
Tumor necrosis factor alpha (TNF-α) and interleukin 
(IL-1β) significantly decreased in diabetic rats 
treated with the extract and β-sistosterol was present 
in the extract [66]. 
Brassica oleracea 
Brassica oleracea (broccoli) belongs to the 
family Brassicaceae. It is said to contain 
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components like minerals, vitamins, dietary fiber, 
hydroxycinnamic acids, flavonol glycosides and 
glucosinolates [67]. In an experimental study, when 
STZ-induced diabetic rats were administered 
polyphenols (5 mL/week) gotten from aqueous 
broccoli extract for 8 weeks, DNA damage reduced 
significantly, GSH and TAC values were 
significantly conserved, and pancreatic 
histopathological changes were attenuated. The 
author concluded that B. oleracea reduced the STZ 
mediated hyperglycemia and the STZ-induced 
oxidative injury to pancreas tissue [67]. In a recent 
study, a single oral administration of aqueous 
extract of B. oleracea at a dose of 60 mg/kg 
significantly decreased blood glucose at the 6
th
 hour 
in STZ-induced diabetic rats. In the study, repeated 
administration of the same dose for 7 days 
significantly decreased the blood glucose to the 
normal level. The author revealed that B. oleracea 
aqueous extract is rich in numerous phytochemical 
compounds and can exert antioxidant activity [68]. 
In another study, 500 mg/kg b.w of B. oleracea 
methanol extract administered to alloxan-induced 
diabetic rats significantly lowered FBG, TC, and 
LDL, whereas the HDL increased in comparison to 
the diabetic control group. The changes were said 
to be similar in comparison to glibenclamide (a 
reference drug) [69]. However, the antioxidant 
activity B. oleracea edible sprouts [70], it 
phytochemical components [71], and amino acid 
compositions [72] have been reported. Furthermore, 
800 mg/kg b.w of B. oleracea aqueous extract 
administered to STZ-induced diabetic rats for 28 
days significantly decreased FBG by about 64% 
within 7 days of treatment. Additionally, HbA1c 
and lipid profile normalized. The authors also 
declared that BUN, Serum glutamic oxaloacetic 
transaminase (SGOT) and Serum glutamic pyruvic 
transaminase (SGPT) significantly decreased, 
meanwhile, activities of CAT and SOD significantly 
increased. However, chlorogenic acid, sinapic acid 
and rutin were present in the extract [73].













Caricaceae  Pawpaw Leaves, fruits 
Preserved integrity of pancreatic islets, improved basal 
insulin secretion and protected cultured call from 
adverse effects of STZ [74]. Exhibited hypoglycemic 
and antioxidant effects and improved lipid profile [75]. 
Improved platelet function and increased total 
antioxidant capacity (TAC) and SOD in type 2 diabetic 
patients [76]. 







Clove  Bud 
Inhibited α-amylase and α-glucosidase activities and 
exhibited antioxidants activities [80].  
3 Ficus carica Moraceae Fig Fruit 
Improved cholesterolaemic status [81]. 
Regulated blood glucose and lipids parameters [82]. 




Moraceae Fig Leaf 
Stimulated insulin secretion and blocked the production 
of hepatic glucose [84]. 
Suppressed hepatic glucose output, improved insulin 
sensitivity and enhanced glucose uptake in type 2 
diabetes mellitus [85]. 
Decreased total and LDL-c concentration [86]. 
Decreased blood glucose to near normal [100, 101]. 
Promoted regeneration of islet, increased antioxidant 










Decreased blood glucose [87, 88, 92, 93, 94 95], serum 
lipid, and lipoprotein [89], serum cholesterol, serum 
triglycerides and serum urea [90]. 
Exhibited increased in plasma insulin level [91] and 
inhibited the activity of hexokinase and glucose 6-
phosphatase [89]. 
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Moraceae Wild fig Stem bark 
Exhibited hypoglycemic effects [96, 97, 98], and 
hypolipidaemic effects [99]. 




Malvaceae  Cotton Seed 
Reduced serum level of glucose, TG, cholesterol, urea 




Combretaceae  Sabara 
Leaves and 
root 
Increased body weight and HDL-c, and decreased 





Meliaceae  Mahogany 
Root, stem, 
bark 
Reduced the level of blood glucose, stimulated 
synthesis of hepatic glycogen, improved tolerance of 
oral glucose and function of β-cell, decreased insulin 
resistance, ameliorated alterations of serum lipids and 
prevented renal and hepatic damages [104]. 









Decreased glucose, cholesterol, and TG concentration 
to normal [107]. 
Improved plasma albumin, lipid profile, serum 







Exhibited dose-dependent inhibition against α-
glucosidase activities [109, 110] and α-amylase [110]. 
Decreased blood glucose level beyond glibenclamide 
effects with increase in the sensitivity of insulin and 
plasma insulin levels [111]. 
 Prevented the decline in body weight and decrease in 
β-cell mass [112]. 
 Improved FBG, HbA1c, hepatic glycogen, plasma 
electrolytes, lipid profile, pancreatic and hepatic MDA, 







Significantly decreased blood glucose in diabetic rats 
and mice [114-130]. 
Reduced triglycerides levels [115]. 
Increased CAT [116, 119, 130], increased SOD [118. 
119. 130] and decreased MDA [116, 118, 119]. 
Increased HDL [120, 121, 122], decreased cholesterol, 
LDL, VLDL and triglycerides [120, 121, 122, 125]. 






Locust bean Seed  
Decreased FBG [132, 133] cholesterol, serum 
triglyceride, LDL-c, VLDL cholesterol and LPO with 
increase in HDL-c and restoration of biomarkers of OS 
[131]. 
Improvement of glucose tolerance and pancreatic β-cell 
function with stimulation of insulin secretion, decrease 
in insulin resistance, restoration of liver glycogen 
amelioration of serum dyslipidaemia and prevention of 
renal and hepatic damages in comparison to the 




Myrtaceae Guava Leaves 
Decreased TC [134, 135 137, 140], LDL [134, 135, 
137, 140], glucose level [134, 136-141], and TG [135, 
137, 140]. 
Increased plasma insulin level [138], HDL [135, 137, 




Solanaceae  Bitter apple Fruit Reduced blood glucose concentration [142]. 
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Bitter leaf  Leaves 
Exhibited antihyperglycemic effects, decreased LDL-c, 
VLDL cholesterol and increased HDL-c in diabetic rats 
[143]. 
Improved glucose tolerance, decreased FBG, TG and 
TC, protected β-cells and increased insulin in diabetic 
rats [144]. Decreased TG and MDA levels and 




Rhamnaceae Buffalo thorn Root, 
Lowered blood glucose, improved glucose tolerance, 
and increased serum insulin and liver glycogen [146].  
Abbreviations: streptozotocin (STZ); total cholesterol (TC); triglycerides (TG); low density lipoprotein cholesterol (LDL-c); 
high density lipoprotein (HDL); low density lipoprotein (LDL), very low density lipoprotein (VLDL); superoxide dismutase 
(SOD); catalase (CAT); malondialdehyde (MDA); glycosylated hemoglobin (HbA1c); high density lipoprotein cholesterol 
(HDL-c); oxidative stress (OS); lipid peroxidation (LPO); fasting blood glucose (FBG) 
 
Conclusions  
In summary, this present study has listed some 
medicinal plants with reported and potential 
antidiabetic effects. Although, most of the research 
used animal models, there is a clear indication that 
medicinal plants with anti-diabetic potentials are 
being investigated by several researchers. 
Unfortunately, most of the investigations are 
preliminary in nature. However, there is a need for 
further research to be conducted with isolated 
bioactive ingredients present in these plants in order 
to have potential compounds that could be used as a 
pharmacological agent in the treatment of diabetes 
mellitus. Again, the mechanisms of action of these 
medicinal plants in ameliorating diabetes need to be 
investigated. Moreover, pharmaceutical industries 
need to support more research activities in this area 
in order to produce and commercially utilize 
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